AMGEN ANNOUNCES WEBCAST OF 2026 SECOND QUARTER FINANCIAL RESULTS

Amgen (NASDAQ:AMGN) will report its second quarter 2026 financial results on Tuesday, August 4, 2026, after the close of U.S. financial markets, followed by an investor conference call at 4:30 p.m. ET with CEO Robert A. Bradway and senior management.

Rhea-AI Summary

Amgen (NASDAQ:AMGN) will report its second quarter 2026 financial results on Tuesday, August 4, 2026, after the close of U.S. financial markets, followed by an investor conference call at 4:30 p.m. ET with CEO Robert A. Bradway and senior management.

A live audio webcast, along with other selected management presentations, will be accessible via the Investors section of Amgen's website and listed on the Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days.

Argus Jul 29 session 37 alerts

-1.39% close to close 0.4x rel. volume Open Argus

Details

News Market Reaction – AMGN

$214.62B Market Cap

On Jul 29, the first trading day after this news, AMGN closed 1.39% below the previous close. Our momentum scanner recorded 37 alerts in the available session data.

Data tracked by StockTitan Argus for the Jul 29 session.

Market Context

AMGN's earnings history included a -4.75% reaction to Q1 2026 results and a +8.15% reaction to Q4 20...

Analysis

AMGN's earnings history included a -4.75% reaction to Q1 2026 results and a +8.15% reaction to Q4 2025 results. Low short positioning and an effective S-3ASR shelf add context.

Key Figures

Reporting Date: August 4, 2026 Conference Call Time: 4:30 p.m. ET Replay Availability: At least 90 days

Reporting Date

August 4, 2026

Second quarter 2026 financial results

Conference Call Time

4:30 p.m. ET

Following the results announcement

Replay Availability

At least 90 days

Webcast archive availability

Previous Earnings Reports

5 past events · Latest: Apr 30

Same Type 5 events

1. Apr 30

   Q1 earnings results

   24h Move

   -4.8%

   Reported Q1 revenue, earnings, margins, cash flow, and full-year 2026 guidance.

2. Apr 24

   Q1 webcast notice

   24h Move

   -1.3%

   Scheduled first-quarter results and a 4:30 p.m. ET conference call.

3. Feb 03

   Q4 earnings results

   24h Move

   +8.2%

   Reported full-year revenue growth, EPS, cash flow, impairment, and mixed product performance.

4. Jan 28

   Q4 webcast notice

   24h Move

   +0.2%

   Scheduled fourth-quarter and full-year results with a 4:30 p.m. ET call.

5. Nov 04

   Q3 earnings results

   24h Move

   +7.8%

   Reported Q3 revenue, EPS, margins, free cash flow, debt retirement, and reiterated guidance.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

THOUSAND OAKS, Calif., July 28, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its second quarter 2026 financial results on Tuesday, August 4, 2026, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 4:30 p.m. ET. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.

Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines.

More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic data to push beyond what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat cancer, inflammatory conditions, rare diseases, heart disease and obesity and obesity-related conditions. 

Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average^®, and it is also part of the Nasdaq-100 Index^®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.

For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, YouTube, Facebook, TikTok and Threads. 

CONTACT: Amgen, Thousand Oaks
Elissa Snook, 609-251-1407 (media)
Casey Capparelli, 805-447-1746 (investors)

View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2026-second-quarter-financial-results-302836979.html

SOURCE Amgen

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Amgen (NASDAQ:AMGN) report its Q2 2026 financial results?

Amgen will report its Q2 2026 financial results on Tuesday, August 4, 2026, after U.S. markets close. According to Amgen, the release will be followed by a webcasted conference call for investors and the public.

What time is Amgen's Q2 2026 earnings conference call for AMGN shareholders?

Amgen's Q2 2026 earnings conference call is scheduled for 4:30 p.m. ET on August 4, 2026. According to Amgen, the call will feature Robert A. Bradway and senior management discussing second quarter 2026 financial results.

How can investors listen to Amgen's Q2 2026 AMGN earnings webcast?

Investors can access Amgen's Q2 2026 earnings webcast via the Investors section of www.amgen.com. According to Amgen, webcast details and links are listed on the Investor Relations Events Calendar on the company’s website.

Will Amgen's Q2 2026 earnings webcast for AMGN be available for replay?

Yes, the Q2 2026 earnings webcast will be archived and available for replay for at least 90 days. According to Amgen, the replay can be accessed through the Investors section and Investor Relations Events Calendar on its website.

Who will speak on Amgen's Q2 2026 AMGN earnings call?

Robert A. Bradway, Amgen’s chairman and chief executive officer, will participate in the Q2 2026 call. According to Amgen, other members of its senior management team will also join to discuss the quarter’s financial results.

Is Amgen's Q2 2026 earnings call open to the public and media?

Yes, the live audio of Amgen's Q2 2026 earnings call is available to media, investors, and the general public. According to Amgen, the event will be broadcast over the internet as a publicly accessible webcast.